Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Establishment of a Treatment System for Hereditary Breast Cancer in Our Hospital].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Dec 2025

Ishibashi Yuko, Anzai Yumi, Kodera Asaka, Fujita Saki, Yukawa Hiroko, Hirano Akira

Abstract excerpt

Genetic medicine related to hereditary cancer syndromes has undergone significant changes in recent years. We have summarized the establishment of a genetic medicine treatment system for breast cancer at our institution. From April 2020 to October 2024, there were 11 cases(1.6% of all breast cancer cases)with pathogenic variants in the BRCA1/2 genes. Among all breast cancer patients, there was 1 case of...

Topics

Join the communities discussing this publication.

Breast Neoplasms
BRCA1 gene
CDH1 gene
NF1 gene
Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Genetic Testing

Source

Identifiers

PMID: 41546351

Genes

BRCA1
CDH1
NF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Establishment of a Treatment System for Hereditary Breast Cancer in Our Hospital].PMID 41546351Read ↗

Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer.Semantic proximity Read ↗

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese PopulationSemantic proximity Read ↗

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).Semantic proximity Read ↗

Screening Familial Risk for Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.Semantic proximity Read ↗

Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report.Semantic proximity Read ↗

Hereditary Breast and ovarian cancer: providing personalized medicine.Semantic proximity Read ↗

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.Semantic proximity Read ↗

[Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].Semantic proximity Read ↗

Investigation on the clinicopathological characteristics and BRCA1/2 gene variation of patients in breast cancer pedigrees in Northern Henan ProvinceSemantic proximity Read ↗

Impact of Updated NCCN Guidelines on Clinical Management and Risk Communication for CHEK2 p.I157T Carriers in Breast CancerSemantic proximity Read ↗

Impact of updated NCCN guidelines on clinical management and risk communication for CHEK2 p.I157T carriers in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.